Therefore, the LAT2-mTOR-LDHB pathway might be a promising therapeutic target in pancreatic cancer, and further study should be conducted to investigate the specific mechanisms between the two positive feedback loops. This evidence concerns the gene MTOR and familial pancreatic carcinoma.